53 related articles for article (PubMed ID: 2045198)
1. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
[TBL] [Abstract][Full Text] [Related]
2. Oncogene amplification in squamous cell carcinoma of the oral cavity.
Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Sumegi J; Klein G; Deo MG
Jpn J Cancer Res; 1989 May; 80(5):430-7. PubMed ID: 2502519
[TBL] [Abstract][Full Text] [Related]
3. FGF amplification an important targeted for head and neck cancer patient? A case report of a patient with FGF amplification treated with erdafitinib.
Gibson N; Larroquette M; Domblides C; Lefort F; Daste A
Eur J Cancer; 2024 May; 202():113986. PubMed ID: 38484691
[No Abstract] [Full Text] [Related]
4. Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews.
González-Moles MÁ; Warnakulasuriya S; López-Ansio M; Ramos-García P
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954497
[TBL] [Abstract][Full Text] [Related]
5.
Baltaci E; Seyhan B; Baykara O; Buyru N
J Cancer; 2017; 8(5):880-886. PubMed ID: 28382151
[No Abstract] [Full Text] [Related]
6. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma.
Takahashi Y; Lee J; Pickering C; Bell D; Jiffar TW; Myers JN; Hanna EY; Kupferman ME
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1926-34. PubMed ID: 26752332
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.
Cho J; Bass AJ; Lawrence MS; Cibulskis K; Cho A; Lee SN; Yamauchi M; Wagle N; Pochanard P; Kim N; Park AK; Won J; Hur HS; Greulich H; Ogino S; Sougnez C; Voet D; Tabernero J; Jimenez J; Baselga J; Gabriel SB; Lander ES; Getz G; Eck MJ; Park WY; Meyerson M
Mol Cancer; 2014 Jun; 13():141. PubMed ID: 24894453
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma.
Jia LF; Wei SB; Gong K; Gan YH; Yu GY
PLoS One; 2013; 8(2):e56634. PubMed ID: 23451060
[TBL] [Abstract][Full Text] [Related]
9. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.
Ather F; Hamidi H; Fejzo MS; Letrent S; Finn RS; Kabbinavar F; Head C; Wong SG
PLoS One; 2013; 8(2):e56112. PubMed ID: 23405260
[TBL] [Abstract][Full Text] [Related]
10. Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.
Young NR; Liu J; Pierce C; Wei TF; Grushko T; Olopade OI; Liu W; Shen C; Seiwert TY; Cohen EE
Mol Oncol; 2013 Jun; 7(3):359-68. PubMed ID: 23200321
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population.
Pai R; Pai S; Lalitha R; Kumaraswamy S; Lalitha N; Johnston R; Bhargava M
Ecancermedicalscience; 2009; 3():128. PubMed ID: 22275997
[TBL] [Abstract][Full Text] [Related]
12. Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers.
Szanyi I; Bauer M; Gerlinger I; Járai T; Gobel G; Lujber L; Szabadi E; Fehér K; Émber A; Ember I; Kiss I
Eur Arch Otorhinolaryngol; 2011 Jul; 268(7):1041-6. PubMed ID: 21120662
[TBL] [Abstract][Full Text] [Related]
13. Her-2 immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, not Her-2 amplification.
Papavasileiou D; Tosios K; Christopoulos P; Goutas N; Vlachodimitropoulos D
Head Neck Pathol; 2009 Dec; 3(4):263-70. PubMed ID: 20596843
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Kawasaki G; Mizuno A; Nemoto TK
Pathol Oncol Res; 2010 Dec; 16(4):523-31. PubMed ID: 20069395
[TBL] [Abstract][Full Text] [Related]
15. The role of chromosomal aberrations in premalignant and malignant lesions in head and neck squamous cell carcinoma.
Abou-Elhamd KE; Habib TN
Eur Arch Otorhinolaryngol; 2008 Feb; 265(2):203-7. PubMed ID: 17701417
[TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of the cyclin D1 gene in head and neck squamous cell carcinoma.
Wang X; Pavelic ZP; Li YQ; Wang L; Gleich L; Radack K; Gluckman JL; Stambrook PJ
Clin Mol Pathol; 1995 Oct; 48(5):M256-9. PubMed ID: 16696017
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations in head and neck squamous cell carcinoma.
Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx.
Koynova DK; Tsenova VS; Jankova RS; Gurov PB; Toncheva DI
J Cancer Res Clin Oncol; 2005 Mar; 131(3):199-203. PubMed ID: 15592685
[TBL] [Abstract][Full Text] [Related]
19. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC).
Lemaire F; Millon R; Young J; Cromer A; Wasylyk C; Schultz I; Muller D; Marchal P; Zhao C; Melle D; Bracco L; Abecassis J; Wasylyk B
Br J Cancer; 2003 Nov; 89(10):1940-9. PubMed ID: 14612907
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of head and neck squamous cell carcinoma.
Hardisson D
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
